WO2001013984A2 - Catheter de drainage lombaire - Google Patents

Catheter de drainage lombaire Download PDF

Info

Publication number
WO2001013984A2
WO2001013984A2 PCT/US2000/040736 US0040736W WO0113984A2 WO 2001013984 A2 WO2001013984 A2 WO 2001013984A2 US 0040736 W US0040736 W US 0040736W WO 0113984 A2 WO0113984 A2 WO 0113984A2
Authority
WO
WIPO (PCT)
Prior art keywords
catheter assembly
catheter
tubular member
lumen
aperture
Prior art date
Application number
PCT/US2000/040736
Other languages
English (en)
Other versions
WO2001013984A3 (fr
WO2001013984A9 (fr
Inventor
Indaka Gunasekara
Mark Griffin
Glenn Frazer
Original Assignee
Neuron Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuron Therapeutics, Inc. filed Critical Neuron Therapeutics, Inc.
Priority to KR1020027002380A priority Critical patent/KR20020026598A/ko
Priority to MXPA02001866A priority patent/MXPA02001866A/es
Priority to JP2001518116A priority patent/JP2003507140A/ja
Priority to AU80340/00A priority patent/AU8034000A/en
Priority to EP00971044A priority patent/EP1207931A2/fr
Priority to CA002382871A priority patent/CA2382871A1/fr
Publication of WO2001013984A2 publication Critical patent/WO2001013984A2/fr
Publication of WO2001013984A3 publication Critical patent/WO2001013984A3/fr
Publication of WO2001013984A9 publication Critical patent/WO2001013984A9/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0043—Catheters; Hollow probes characterised by structural features
    • A61M25/0045—Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body

Definitions

  • This invention generally relates to cerebral and lumbar catheterization apparatus for perfusing and draining fluids from the cerebral and spinal regions.
  • this invention is a lumbar drainage catheter for accessing the cerebrospinal fluid (CSF) pathways and efficiently removing fluids from those passageways.
  • CSF cerebrospinal fluid
  • One difficulty with effective treatment is related to the speed with which a stroke inflicts cellular damage.
  • ischemic stroke the cascade caused by the stroke-initiated infarct occurs rapidly.
  • prompt medical treatment typically within about six hours of the stroke event, brain cells in the penumbra surrounding the infarct will die.
  • vascular tissue in this penumbra does not exhibit notable necrosis until about 24 hours after the stroke-causing occlusion is formed, vascular tissue and smaller arterioles are susceptible to irreparable damage within 30 minutes of occlusion. Edema also begins to occur throughout the penumbra due to reduced cellular ion pump activity; this will result in swelling of the neural tissue and accelerated neural tissue damage.
  • One method for providing timely therapy to neural tissue under such severe ischemic conditions is introducing an oxygenated fluorocarbon nutrient emulsion (OFNE) through a portion of the ventriculo-subarachnoid spaces surrounding the brain and spinal cord where the cerebrospinal fluid (CSF) exists.
  • OFNE oxygenated fluorocarbon nutrient emulsion
  • Emulsions such as those described in U.S.
  • Patent No. 4,981,691 to Osterholm et al., the entirety of which is herein incorporated by reference, are well-known in the art.
  • OFNE treatment is intended to provide much-needed oxygen and nutrients to neural and vascular tissue until collateral circulation develops or the occlusion resolves. It offers a powerful emergency therapy for those individuals suffering the first symptoms of ischemic stroke.
  • circulation systems such as those disclosed in U.S. Patent Nos. 4,393,863 and.
  • Such fluids are introduced into the brain ventricles via specialized perfusion catheter arrangements such as those described in U.S. Patent No. 4,840,617, to Osterholm. These catheters are specially designed for penetrating the skull, safely navigating brain tissue to the brain ventricle, and reliably delivering OFNE to the CSF pathway.
  • Such fluids are removed from the CSF pathways by use of specialized drainage catheters.
  • OFNE a type of hemmorhagic stroke known as a subarachnoid hemorrhage, in which an aneurysm bursts in a large artery on or near the dural matter surrounding the brain, blood may enter into the CSF pathway and present the need for draining the contaminated CSF.
  • disorders such as cerebral edema, neurosurgical sequlae, encephalitis, or neoplastic disease, as well as severe head or spinal trauma may present the need for draining or tapping the CSF.
  • patients with hydrocephalus a condition in which there is an abnormal increase in the amount of CSF within the cranial cavity, are presented with life-threatening levels of elevated intracranial pressure that must be relieved by drainage.
  • Such drainage may be accomplished by tapping into the CSF pathway via a specialized drainage catheter in a number of locations, including the ventricles of the brain, the cisterna magna, and the subarachnoid space in the spinal column, for example.
  • the exact location from which a physician chooses to access the CSF pathway will depend upon a number of factors, including the indication being treated, the condition of the patient, the type of treatment selected, etc.
  • the catheter For drainage catheters designed to access the CSF pathway through the lumbar region, a number of considerations must be taken into account ⁇ especially when they are used in conjunction with OFNE perfusion.
  • the catheter must have appropriately-sized apertures and an internal lumen for allowing fluid flow to freely take place at designated flow rates and pressure ranges while preventing blockage by the cauda equina (spinal nerve roots) or the arachnoid membrane.
  • the catheter diameter and the tip must be appropriately designed to access the subarachnoid space of the spine with minimal trauma to the patient, yet must be able to resist kinking or crushing upon entry through the dermal back tissue and the tough dura mater outside the subarachnoid space.
  • the catheter should also be radiopaque so that its visibility can be maximized to verify placement.
  • This invention is a lumbar drainage catheter assembly made up of a polymeric single- or multiple-wall elongate tubular member forming a lumen and having an exterior wall, a distal end, and a proximal end.
  • the tubular member and in particular, a distal portion of the tubular member, is of a size and flexibility suitable for entry into a subarachnoid space without substantial trauma to neural tissue and yet is very resistant to crushing and to kinking during use.
  • the tubular member typically has at least one aperture through its wall. The apertures are usually spaced away from the distal end of the catheter.
  • the size of the lumen, the overall length of the catheter assembly, and the size, placement, and number of apertures through the tubular member wall and certain other variables related to fluid flow are chosen so that during normal use, the catheter can accommodate CSF flowrates of 3-150 ml/min (preferably greater than 50ml/min.) at driving pressures of about 15 cm H 2 O.
  • the distal end of the catheter assembly may either be closed or open, depending on the particular application required.
  • the catheter When the distal end is open, the catheter is adaptable for passage of a guidewire completely therethrough and allows for greater fluid flow from the exterior of the catheter through the lumen to assist in the drainage process.
  • a soft polymeric distal tip plug may, instead, be situated in the distal-most end of the catheter lumen to provide added mass and to minimize trauma to the tissue of the lumbar region surrounding the spinal column. This plug may be solid or have one or more channels or lumens to allow fluid to flow therethrough.
  • the proximal section of the catheter elongate tubular member is stiffer than the distal section.
  • the catheter assembly elongate tubular member may also contain an inner polymeric liner defining the lumen and an outer cover coaxial to said inner polymeric liner which defines the exterior surface.
  • a woven braid or coil may be situated coaxially between the liner and cover.
  • the proximal portion of the outer cover may be stiffer than the distal portion of the outer cover.
  • the coil or braid may be of stainless steel, super-elastic alloys, polymers, or mixtures thereof. It should be MRI compatible. It may be made of filamentary components such as wire, ribbon, thread, or their mixtures.
  • At least a portion of the elongate tubular member may be radio-opaque.
  • a radio-opaque filler such as barium sulfate, bismuth oxide, bismuth oxychloride, bismuth carbonate, powdered tungsten, powdered tantalum and mixtures thereof may be used.
  • one or more radio-opaque markers may be included to provide visibility to the catheter assembly.
  • This invention may also include a flexible guidewire which is inserted within the catheter lumen from the catheter proximal end. It is preferred, but not necessary, that such a guidewire when unrestrained by the catheter lumen has a naturally nonlinear, semicircular, or "J" form.
  • the catheter takes on a shape influenced by the nonlinear guidewire form. Preferably, such shape is presented as about a 5° to 15° bend in the distal portion of the catheter-guidewire combination. This facilitates entry into the spinal subarachnoid space in the direction of the patient's head.
  • the flexible distal section of the catheter assembly may also have an unrestrained shape so that after deployment in the subarachnoid space and the guidewire is withdrawn, the elongate tubular member self-forms into an elbow that bends approximately 90°.
  • This elbow is preferably, but not necessarily, proximal of at least one of the catheter apertures so as to promote fluid drainage.
  • the catheter is also designed to work in conjunction with a Touhy needle to facilitate insertion of the catheter through the dermal, cartilaginous and other tissues surrounding the subarachnoid space.
  • This Touhy needle generally has an interior lumen through which the inventive catheter and guidewire may be introduced.
  • the Touhy needle may have a curved distal end to guide or to urge the catheter, usually with an included guidewire, in the direction of the patient's head or feet, whichever is clinically indicated.
  • the surface of the elongate tubular member exterior wall typically is coated with a lubricious, hydrophilic layer.
  • Figure 1 is a schematic lateral cross-section of the spinal column and nerve roots detailing various tissues in the region of the L4 and L5 vertebrae.
  • Figure 2 A shows, in longitudinal cross section, one design of the lumbar catheter of the present invention.
  • Figure 2B is a longitudinal cross section of the distal end of a variation of the lumbar catheter of the present invention having a distal aperture and channel for fluid flow therethrough.
  • Figure 3 A shows a partial side view of an aperture having a modified entrance region.
  • Figure 3B shows a front view of the aperture of Figure 3 A.
  • Figure 4A shows a partial sideview of a second variation aperture having a modified entrance region.
  • Figure 4B shows a front view of the aperture of Figure 4 A.
  • Figure 5 shows a sideview of a portion of the inventive catheter with external spacing fibers.
  • Figure 6 A shows a sideview of a portion of the inventive catheter with external spacing ribs.
  • Figure 6B shows a sideview of a portion of the inventive catheter with external spacing ribs.
  • Figure 6C shows a sideview of a portion of the inventive catheter with external spacing ribs.
  • Figure 7 A shows, in partial longitudinal cross section, another design of the lumbar catheter of the present invention having a reinforced section.
  • Figure 7B shows the lumbar catheter of Figure 7A in transverse cross section along the line B-B.
  • Figure 7C shows the lumbar catheter of Figure 7A in transverse cross section along the line C-C.
  • Figure 7D shows the lumbar catheter of Figure 7 A in transverse cross section along the line D-D.
  • Figures 8A-8C show partial cutaway views of the catheter of the present invention showing variations of the anti -kinking member.
  • Figures 9A and 9B show, respectively, sideview and top views of further variations of the catheter of the present invention.
  • Figures 10A and 10B show, respectively, sideview and top views of further variations of the catheter of the present invention.
  • Figure 11 depicts a kit made according to the present invention including a catheter of the present invention, a guidewire, a Touhy needle, and an obdurator.
  • Figures 12A-12D show schematic views of the catheter of the present invention and how it assembles with a shaped guidewire and Touhy needle for insertion into the lumbar region.
  • Figure 13 is a depiction of the human cerebrospinal fluid circulation system and one configuration of using the lumbar catheter of the present invention in conjunction with an inflow catheter to perfuse and drain oxygenated fluorocarbon nutrient emulsion from the cerebrospinal fluid circulation pathway.
  • Figures 14A and 14B show side views of a catheter stay suitable for use with this invention.
  • This invention includes a lumbar drainage catheter assembly for accessing the CSF pathway, or the subarachnoid space, via the lumbar region of the human spine.
  • One single- wall variation includes a stiffer proximal section having a higher material hardness so to resist kinking and compression during deployment and use.
  • a less stiff, softer distal section perhaps having a soft polymeric, distal plug provides needed flexibility and assures minimal tissue damage.
  • a number of openings through the catheter wall allows CSF, OFNE, or other therapeutics or diagnostics to drain from the spinal subarachnoid space into the catheter lumen out through an open proximal end.
  • a double-wall variation includes a braid, perhaps woven, or a coil or coils in the proximal section to provide added stiffness, and, more importantly added compression and kink resistance, to the catheter.
  • Either variation may be used with a guidewire and Touhy needle for precise placement into the delicate subarachnoid space.
  • Figure 1 is a partial lateral cross-section of the human spinal column (100) in the area most appropriate for application of the lumbar catheter discussed below.
  • this cross-section depicts the spinal column (100) around the L4 (designated with reference numeral (110)) and L5 (designated with reference numeral (120)) vertebrae.
  • the tough and fibrous dura mater (130) is the outermost membrane protecting the spinal cord.
  • Situated adjacent the dura mater (130) is the subdural space (150), which is bordered by arachnoid (140), another more delicate membrane covering the spinal cord.
  • the pia mater is a further discrete membrane covering each individual nerve root.
  • the subarachnoid space through which CSF flows is designated in Figure 1 as element (160).
  • the subarachnoid space (160) serves as a reservoir also housing the spinal cord, or, in the region depicted in Figure 1, the cauda equina (170).
  • the cauda equina (170) are the collection of spinal roots that descend from the lower part of the spinal cord (not shown) in the lumbar region.
  • OFNE is perfused from the cerebral ventricles through the dural tube down along the spinal cord to the lumbar region as in Figure 1.
  • the lumbar catheter of the present invention accesses the subarachnoid space (160) from, for instance, the gap between L4 (110) and L5 (120) and drains the OFNE therefrom.
  • One catheter assembly which incorporates the concepts of this invention is shown in longitudinal cross section in Figure 2A.
  • Catheter (200) is characterized by a single-wall elongate tubular member forming a lumen (260) and exterior wall and having a proximal end (205) and distal end (210).
  • the elongate tubular member consists of a proximal tubular section (220) and a distal tubular section (240). Such a construction gives catheter (200) multiple bulk elastic moduli along its length.
  • the typical configuration shown in Figure 2 A has a moderately stiff proximal section (220) to prevent its crushing or kinking when present in the ligature of the back, a distal shaft section (240) which is typically more flexible to minimize kinking due to moduli differences, and soft polymeric tip plug (280) for minimizing trauma to the dural tissue and promoting proper placement of the catheter.
  • Tip plug (280) resides in the lumen (260) shown in distal tubular section (240) and may also occupy a portion of lumen (260) in proximal section (220).
  • catheter (200) The typical dimensions of catheter (200) are:
  • the specific dimensions are not particularly critical to this invention except to the extent that they promote or inhibit flow of the CSF, as discussed below.
  • the specific dimensions may be varied as the location of use and particular function required of the catheter vary.
  • a proximal section (220) length of between about
  • a distal section (240) length of between about 10 and 15 mm is desired.
  • Plug (280) preferably has a length of between about 1.0 and 4.0 mm; more preferably about 1.5 to 2.0 mm.
  • the overall length of catheter (200) is generally between about 190 and 210 mm.
  • Proximal section (220) makes up the majority of the length of catheter (200), and serves several purposes. As described above, one particularly important purpose is to provide enough bulk stiffness and form to the catheter to ensure that the catheter is not kinked or crushed when the catheter is in use.
  • the proximal portion (220) of catheter (200) should also be sufficiently stiff to allow the user to push the catheter (200) through the Touhy needle (discussed and shown below) during placement of the catheter.
  • proximal section (220) Passage through membranes such as the tough dura mater (130), associated muscles, tendons, and the arachnoid (140) to access the subarachnoid space (160) without such kinking or crushing is a requirement served by such a proximal section. It is also desirable that the inner lumen (260) within at least a portion of the proximal section (220) be larger than the lumen in the distal section (240) so to enhance the overall flow capabilities of the catheter. Another purpose of proximal section (220) is optionally to provide for one or more apertures (270) for the drainage of CSF or OFNE when the catheter is in place. The proximal section (220) also provides an interface at proximal end (205) through which the catheter (200) may join or interact with other equipment, etc. in the manner appropriate for the particular application for which the catheter is being used.
  • the proximal section (220) of catheter (200) may be of a single-wall construction of a thin polymeric tubular member.
  • the outer diameter of proximal section (220) may be between about 50 and 100 mils and more preferably between about 55 and 75 mils.
  • the inner diameter of proximal section (230) may be between about 30 and 70 mils and preferably between about 40 and 60 mils.
  • the optimal inner diameter of proximal section (220) will be ultimately determined to attain maximum volume of fluid flow over a given period of time while not compromising the structural integrity of the catheter assembly (200). It is contemplated that for application in the CSF pathway, the catheter should accommodate flow rates of between about 3 and 150 ml/minute, preferably between about 5 and 75 ml/minute, more preferably about 40 ml/minute, and most preferably about 50 ml/minute each at approximately 15 cm H 2 O of fluid driving pressure.
  • the size of the lumen (260), the overall length of the catheter assembly (100), and the size, placement, and number of apertures (270) through the tubular member wall and certain other variables related to fluid flow are chosen so that during normal use, the catheter can accommodate the desired CSF and included drug flowrates. These dimensions are chosen and interrelated depending on the performance characteristics required.
  • polyurethanes particularly useful classes of polymers are polyurethanes, various polyethylenes (including low density polyethylene (LDPE), linear low density polyethylene (LLDPE)), polypropylene, polybutenes, polyamide (such as Nylons), high density polyethylene (HDPE), polyimides, polyvinylchloride, fluorocarbon resins (e.g., PTFE, FEP, vinylidene fluoride, their mixtures, copolymers, block copolymers, etc.), etc., and other polymers of suitable hardness and modulus of elasticity. Blends, alloys, mixtures, copolymers and block copolymers of these materials are also suitable if desired. We have found that medical grade urethane sold under the name TECOFLEX (Thermedics, Inc., Waltham,
  • MA having a Shore hardness of approximately 80A-200A, preferably about 95A-125A is suitable.
  • proximal section (220) may be stiffened by increasing its wall thickness. This will alter its bulk elastic performance under the conditions contemplated.
  • the fenestrations or apertures (270) are shown, in this variation, to be situated both within the proximal and distal (240) sections of the catheter assembly (205). Typically, though, the apertures (270) are placed only in the distal section (240). In some variations of the invention, we have eliminated the fenestrae (270) from the distal-most 3mm of the distal section (240). The only substantial limitation of the aperture placement is that the apertures should not be either outside of the body or situated in the subdural space when finally and properly situated within the patient.
  • openings (270) are necessary for fluid flow between, and preferably from, an area external to the catheter into the lumen (260) of proximal section (220). Ideally, they are of a diameter, spacing, and pattern that maximizes the flow rate of fluids such as CSF, OFNE, drugs or diagnostics from the subarachnoid space through lumen (260) towards proximal end (205). Once at proximal end (205), fluids may be collected from lumen (260) for diagnostic monitoring or the like.
  • fluids such as CSF, OFNE, drugs or diagnostics
  • Fenestrae (270) generally have a relatively small diameter so to optimize the twin goals of maximizing fluid flow rates and maintaining the structural integrity of catheter (200). Another consideration for application in the subarachnoid space is the possibility that individual nerve root fibers of the cauda equina could partially or completely block fluid flow through one or more apertures (270), hindering the efficiency of the catheter drainage function.
  • the apertures (270) shown in Figure 2A typically have diameters in the range of 0.010" to 0.060" depending upon the diameter of the catheter and the ability of the catheter to maintain the CSF flow-rates discussed above. It is within the scope of this invention to utilize multiple apertures (270) having diameters down to, e.g., 25 microns or so.
  • the distal section (240) comprise a fabric containing these micro-apertures (270).
  • these inventive catheters are preferably used with Osterholm' s OFNE, discussed above, which is preferably an emulsion, the apertures must not be of a size so small that they upset the micellar structure of the emulsion.
  • Catheter (200) of Figure 2A depicts four rows of seven apertures (270). In this configuration, the apertures are spaced about 3.8 mm apart in each of four rows arranged symmetrically about the catheter's central axis. Note also that the centers of the apertures in a given row are aligned with those in the opposing row; however, these same centers are offset from those in any adjacent row along the catheter central axis.
  • This pattern is merely exemplary as are the Figure 2 A aperture
  • the fenestrae (270) diameter and spacing are integers.
  • the fenestrae (270) be arranged in a spiral or other nonlinear or random pattern, or have variable spacing or diameters as desired.
  • the spinal roots in this portion of the subarachnoid space are free to move about there. They are very soft in texture and may clog the fenestrae (270) when CSF is withdrawn at high rates. Consequently, to lessen the possibility of this happening, a number of things may be done.
  • the apertures may be modified to broaden the suction zones of the apertures.
  • projections may be placed on the outer surface of the catheter in the region of the apertures.
  • the shape of the catheter may be selected (and the placement of the apertures carefully selected) to minimize the propensity of the apertures to draw the nerve roots to the flow region near those apertures.
  • Figure 3 A shows a cross-sectional side-view of an aperture (280) having a depressed, perhaps generally conical, entrance (or exterior) region (282) in a catheter wall (284).
  • the depressed region (282) will help to maintain the nerve root away from the higher flow rate aperture (280).
  • Figure 3B shows a partial front view of the aperture (280), and the depressed entrance region (282) in the catheter wall (284).
  • Figure 4A shows a cross-sectional side-view of an aperture (286) having a shaped depressed entrance region (288) in a catheter wall (284).
  • the shaped depressed region (288) provides a region which has a substantial length in a generally circumferential groove around the catheter. This may be desirable since the nerve roots generally run parallel to the longitudinal axis of the catheter when the catheter is in use.
  • Figure 4B shows a partial front view of the aperture (286), and the depressed entrance region (288) in the catheter wall (284).
  • Figure 5 shows a catheter section (300) having various apertures (270) and a number of brush-like projections (302) near the apertures (270).
  • These brushes (302) must be very soft and flexible. Specifically, they must not cause injury to the nerve roots in the subarachnoid space when moved through that space during the introduction of the catheter; the brushes must easily fold during their passage through the Touhy needle and therefor not add those problems to the introduction of the catheter section (300) into the spine. As was the case just above, these projections (302) will keep the nerve roots away from the apertures (270) and lessen the chances that the nerve roots will clog the apertures.
  • Figure 6 A shows a catheter section (300) having circumferential ribs (306) adjacent the apertures (270). Circumferential ribs (306) hold the nerve roots away from the apertures (270).
  • the circumferential ribs (320), as shown in Figure 6B, may be inflatable using, e.g., a separate lumen for the inflation fluid.
  • the projecting nibs (322) shown in Figure 6C may be inflatable.
  • proximal end (205) is generically illustrated as an open- ended termination point of catheter (200).
  • this configuration allows catheter (200) to be connected to a variety of components.
  • tubing may be placed over the outer diameter of proximal section (220) so to capture fluid flowing through apertures (270) into lumen (260) for further collection or disposal.
  • proximal end (205) so to adapt catheter (200) for connection to a wide variety of components with a number of different configurations as will be clear to those of skill in the art.
  • Distal section (240) is preferably made from a polymeric material largely as described above for proximal section (220). The most important factor distinguishing distal section (240) from proximal section (220) is the lower elastic modulus and/or hardness of distal section (240), which is desired so that the distal end (210) of catheter (200) may be adequately maneuvered into the subarachnoid space without significant trauma.
  • TECOFLEX medical grade urethane having a Shore hardness of approximately 80A-190A and preferably about 85A-110A is suitable for distal section
  • (220) can comprise distal section (240) as long as the overall flexibility of the distal section
  • distal section (240) is higher than that of proximal section (220).
  • the physical dimensions (i.e. inner and outer diameters) of distal section (240) will generally be the same as those discussed with respect to the distal section (240) although it is sometimes desirable to utilize a comparatively smaller diameter distal section (240) to improve the flow capabilities of the catheter assembly.
  • Proximal section (220) and distal section (240) are joined together at joint (290).
  • joint (290) the tubing making up the two sections are butted (or overlapped) on a TEFLON-coated inner mandrel and beneath an outer glass retainer and heat welded, adhered, or solvent welded together.
  • joint (290) may comprise a discrete material different from that of either proximal section (220) or distal section (240).
  • Joint (290) is preferably formed so as to maintain smooth and continuous interior and exterior surfaces of the catheter. Such an interior surface minimizes drag on, and turbulence created in, fluid flowing through lumen (260). It also ensures that materials or instruments such as a guidewire may be inserted and removed from lumen (260) with minimum effort or obstruction.
  • a smooth exterior surface promotes easy insertion to and removal from a Touhy needle and, more importantly, minimizes trauma to tissue.
  • Polymeric tip plug (280) is shown in the distal-most end of catheter (200) in Figure 2A. This soft insert is typically between about 0.25 and 5.0 mm in length; more preferably between about 1.5 and 2.0 mm.
  • the diameter of plug (280) is chosen to be slightly smaller than the inner diameter of distal section (240).
  • Plug (280) is preferably made of a softer polymer than that of distal section (240).
  • polyurethane copolymer sold as TECOFLEX having a Shore hardness between about 70A and 150A, preferably between about 75 A and 95 A.
  • Such a soft tip provides added mass to the blunt distal end (210) of the catheter, promoting correct placement in the subarachnoid space (160) with minimal trauma. This allows for shorter healing times of the entry wound and helps to minimize risk of post- procedure infection.
  • Distal end (210) is depicted in Figure 2A as closed to the exterior and to lumen (260). It is within the scope of the present invention, however, that this section (210) be open so that fluid flows through one or more apertures (270) in distal section (220) in the vicinity of the distal end (210), through or around (via a channel, etc.) tip plug (280) and into lumen (260).
  • One such arrangement with a single distal aperture is shown in Figure
  • At least a portion of the exterior wall of catheter (200) (and those of the other inventive catheter variations discussed herein) be coated with a lubricious and typically hydrophilic layer, which either is chemically bonded or physically coated onto the catheter exterior surface.
  • a lubricious and typically hydrophilic layer which either is chemically bonded or physically coated onto the catheter exterior surface.
  • a description of suitable procedures for producing such lubricious coatings is found in U.S. Patent No. 5,531,715 to Engelson et al. and U.S. Patent No. 5,538,512 to Zenzen et al. the entirety of each are which incorporated by reference.
  • a preferred hydrophilic coating is a polypyrrolidone-based material sold by Hydromer Co. Although less preferred, silicone oils such as MDX are suitable.
  • FIG. 7A-7D A second variation of the present invention is shown in Figures 7A-7D.
  • This catheter is similar to the variation of Figure 2A, with a proximal end (305), a proximal section (320), a closed distal end (310) and a distal section (330); however, the entire catheter (300) has a dual-tubing shaft over its entire length.
  • the proximal section (320) contains a stiffener or kink-resisting member (340), e.g., a woven braid, a laid-up braid, or one or more coils, interposed between the two polymeric shafts to reinforce, to provide kink resistance, and to provide additional stiffness to the proximal section (320) of the catheter.
  • a stiffener or kink-resisting member e.g., a woven braid, a laid-up braid, or one or more coils, interposed between the two polymeric shafts to reinforce, to provide kink resistance, and
  • a main tubular catheter body shaft or inner polymeric liner (325) is situated within at least a portion, and preferably over the entire length of catheter (300) and provides the basic structure of the device.
  • This liner may be of any of the suitable polymers discussed above, but preferably made from TECOFLEX urethane tubing having a Shore hardness of approximately 80A- 190A and preferably about 85 A- 110A.
  • tubular polymeric liner (325) is preferably between about 30 and 70 mils and more preferably between about 40 and 60 mils.
  • the wall thickness of shaft (325) is thus sized accordingly. These dimensions are obviously not critical and may vary from those cited above depending on the performance characteristics required.
  • the optimal inner diameter of tubular member (325) will be ultimately determined to attain maximum volume of fluid flow in a given period of time while not compromising the structural integrity of the catheter assembly (300).
  • Figure 3B shows in radial cross-section the innermost tubular shaft (325) that often extends the entire length of catheter (300).
  • proximal section (320) is woven braid or coil (340), which is interposed coaxially between liner (325) and a stiffer proximal outer cover or tubular shaft (330).
  • Braid or coil (340) provides additional mass and stiffness, and serves to ensure that the catheter resists kinking or crushing when traversing the tough membranes such as the dura mater (130), muscles, ligaments, and arachnoid (140) as previously discussed.
  • Figs. 8 A, 8B, and 8C show variations of the kink resistant member in partial cross- section.
  • Fig. 8A shows a catheter section (342) having a coil kink-resistant member (344) situated between the inner liner (343) and an outer cover (345).
  • This section (342) is usually the proximal section of the catheter, although it need not be.
  • Figure 8A are the optional features that apertures (347) are found in the proximal section, that the coil (344) has a varying pitch, and that the apertures (347) are in a generally spiral formation. It should be apparent that the coil pitch (and the braid pitch) control the stiffness of the catheter for a given wire or ribbon size.
  • Fig. 8B shows a woven braid (349) situated in the wall of the catheter assembly (351).
  • a "woven" braid means that the individual wires or ribbons cross each other radially, in-and-out, as they pass axially down the length of the catheter.
  • This is in contrast to the "unwoven" braid (353), shown in Fig. 8C, in which one layer of individual wires or ribbons making up the braid (353) in the catheter section (354) are simply wound one-way and then another layer of wires or ribbons are wound the other way, i.e., left-handed and then right-handed, one layer of coil windings on top of the other layer.
  • woven braid or coil (340) may be made from various filamentary components, such as wire, ribbon, thread, etc. and mixtures thereof.
  • filamentary components such as wire, ribbon, thread, etc. and mixtures thereof.
  • the particular choice of filamentary components making up braid or coil (340) will depend on the particular mechanical properties desired, cost and manufacturing considerations, etc.
  • the coil or woven braid can be made from, in whole or in combination, metals such as platinum, palladium, rhodium, gold, tungsten, titanium, tantalum, nickel, alloys thereof, stainless steel, and polymers.
  • metals such as platinum, palladium, rhodium, gold, tungsten, titanium, tantalum, nickel, alloys thereof, stainless steel, and polymers.
  • the material should be MRI compatible.
  • a particularly useful class of alloys for the filamentary components of woven braid or coil (340) are of a member of a class of alloys known as super-elastic alloys.
  • Freferred super-elastic alloys include the class of titanium/nickel materials generically known as nitinol — alloys discovered by the U.S. Navy Ordnance Laboratory. These materials are discussed at length in U.S. Patent Nos. 3,174,851 to Buehler et al., 3,351,463 to Rozner et al., and 3,753,700 to Harrison et al.
  • alloys containing up to about 8% or more, of one or more other members of the Iron Group of the Periodic Table, e.g., Fe, Cr, Co, are considered to be encompassed within the class of super-elastic Ni/Ti alloys suitable for this service.
  • Desirable alloys having a transition temperature below body temperature, and desirably of less than 0° C are useful.
  • an additional step may be desirable to preserve the shape of the stiffening braid.
  • some heat treatment is desirable. Braids which are not treated in this way may unravel during subsequent handling or may undertake changes in diameter or braid member spacing during that handling.
  • the braid is placed onto a mandrel, usually metallic, of an appropriate size. The braid is then heated to a temperature of 650°-750°F for a few minutes, possibly (but not necessarily) annealing the constituent ribbon. After heat treatment, the braid retains its shape and the alloy retains its super-elastic properties.
  • the ribbons making up the braid or coil (340) shown in Figure 7B may also contain a minor amount of non-super-elastic alloy materials.
  • metallic ribbons are preferred as the ancillary materials because of their strength-to- weight ratios, fibrous materials (both synthetic and natural) may also be used.
  • Suitable non-metallic ribbons include high performance materials such as those made of polyaramids (e.g., KEVLAR), liquid crystal polymers (LCP's), and carbon fibers. Preferred, because of cost, strength, and ready availability are stainless steels (SS304, SS306, SS308, SS316, SS318, etc.) and tungsten alloys.
  • more malleable metals and alloys e.g., gold, platinum, palladium, rhodium, etc. may be used.
  • a platinum alloy with a few percent added tungsten is preferred partially because of its radio-opacity.
  • the braids utilized in this invention may be made using commercially available tubular braiders.
  • the term "woven braid” is meant to include tubular constructions in which the wires or ribbons making up the construction are woven radially in an in-and-out fashion as they cross to form a tubular member defining a single lumen.
  • the braids may be made up of a suitable number of ribbons, typically six or more. Ease of production on a commercial braider typically results in braids having eight or sixteen ribbons.
  • Braid (340) can be either a single, double, or multiple-ribbon or -wire wind.
  • Single- ribbon or wire winds permit the braid to contain the maximum amount of open area between ribbons in the braid.
  • a double-wind variation a pair of ribbons or wires is placed side by side. This variation produces a braid which is denser than the single wind. It is also thicker. Typically, the regions between adjacent winds are smaller.
  • the invention described herein is intended to encompass multiple-wind braids.
  • the stiffness of the proximal section (320) substantially increases as the number of wires or ribbons used in a multiple-weave is increased, or as the spacing between coil windings is decreased, it is within the scope of this invention to tailor the braid or coil (340) so to obtain the desired stiffness of proximal section (320).
  • the braid or coil (340) typically will have a nominal pitch angle (to the catheter axis) of 45°. Clearly the invention is not so limited. Other angles from 7.5° to 60° are also suitable.
  • a variation of this invention is the ability to vary the pitch angle of the braid or coil (340) either at the time the braid or coil (340) is produced or at the time the braid or coil is included in the catheter proximal section (320).
  • Woven braid or coil (340) is present throughout the entire proximal section (320) of catheter (300), and preferably extends from the most proximal end of the catheter to within approximately 10 mm of the most proximal aperture (360). However, the invention is not so limited, and braid or coil (340) can, if necessary, extend distally throughout the entire length of catheter (300).
  • catheter (200) of Figure 2 A additionally comprise a braid or coil such as braid (340) discussed above.
  • the braid or coil would preferably be disposed interior to proximal section (240), and even distal section (240), in lumen (260).
  • such braid or coil (340) may be simply press fit into the catheter shaft or may be bonded using available mechanical, thermal, and chemical bonding techniques.
  • a polymeric layer may be bonded to braid or coil (340) in such a configuration so to present the lumen (260) with a continuous, smooth surface as discussed above.
  • proximal outer cover or tubing (335) surrounds braid or coil (340) and is mechanically, thermally, or chemically bonded to braid or coil (340).
  • the inner liner (325) and braid or coil (340) are slid into a polyurethane tubing.
  • the assembly is then placed inside a temporary shrink-wrappable polymeric tubing of, e.g., polyethylene or Teflon, and the whole assembly is heated. The heating both shrinks the temporary shrink- wrappable polymeric tubing and preferably passes through the glass point of the polymer in the outer cover (335).
  • the outer cover (335) is squeezed onto the braid or coil (340) and, upon cooling, the assembly is an integral whole.
  • the temporary shrink-wrappable polymeric tubing is then peeled off.
  • Any of the biocompatible polymeric materials, particularly those materials discussed above, that are suitable for medical application and that meet the requirements of the catheter assembly can be used for outer cover (335). Particularly useful is the material sold as TECOFLEX having a Shore hardness of approximately 85A-200A and preferably about 90A-110A.
  • Proximal outer cover (335) extends from the proximal end (305) of catheter (300) through proximal section (320) to joint (350) as shown in Figures 7A, 7B, and 7C.
  • the outer diameter of proximal outer cover (335) is preferably between about 50 and 80 mils.
  • the inner diameter will of course, be designed to best fit over liner (325) and braid or coil (340).
  • Figure 7C details in cross section proximal outer cover (335) in relation to inner liner (325) in the region of the apertures.
  • joint (350) cover (335) is joined to distal outer cover or tubular shaft (345), which is in turn joined to liner (325) as previously described. It is desirable that joint (350) forms a continuous and smooth bond between liner (325) and cover (335). Joint (350) is shown in Figure 7 A as located distal of the distal -most aperture (370) and proximal to polymeric tip plug (380). However, the location of joint (350) may be varied in either direction along the catheter axis depending on the performance requirements and manufacturing concerns for the particular catheter in consideration.
  • Distal section (330) is that portion of catheter (300) distal to mid-section (320) and to proximal section (310).
  • the outer layer (345 in Fig. 7D) of distal section (330) may be an extension of the proximal outer cover or tubular shaft (335), but need not be as shown where the distal outer cover or tubular shaft (345).
  • distal outer cover (345) as shown in Figures 7A and 7D extends from joint (350) around the distal-most end of catheter (300) and encompasses polymeric tip plug (380). It preferably has an outer diameter of between about 50 and 80 mils.
  • Polymeric tip plug (380) is shown disposed in the lumen (360) of catheter (300), and serves the same purpose as tip plug (280) of catheter (200) as discussed with relation to Figs. 2 A and 2B.
  • catheter (300) may also have an open distal end with one or more apertures to enhance drainage of fluid through the catheter lumen and to possibly allow passage of a guidewire therethrough.
  • All of the polymeric portions of the catheter assembly in the various Figures, including the proximal and distal shafts, both inner and outer, as well as the plug, may be radio-opaque for visibility under fluoroscopic examination. This allows the physician to more readily verify placement of the catheter.
  • radio- opaque filler materials such as barium sulfate, bismuth oxide, bismuth trioxide, bismuth oxychloride, bismuth carbonate, powdered tungsten, powdered tantalum, or the like. It is preferred, but not critical, that the radio-opaque material make up about 40% (wt) of the polymeric material so maximum visibility can be had.
  • the catheters of the present invention may be made radio-opaque, if so desired, by the placement of rings or other markers of radio-opaque metals such as platinum, etc. at appropriate locations along the length of the catheter.
  • Figures 9A, 9B, 10 A, and 10B show two other variations of the inventive catheter that may utilize either of the physical makeup discussed in relation to Figs. 2 A and 7A.
  • Figure 9 A shows a side view of a corkscrew-like catheter (362) with apertures (364) which are preferably within the inside of the turns of the cork-screw.
  • the distal-most section (366) of the catheter (362) is straight.
  • the depicted shape has the following benefits, and is specifically to help deny the nerve roots in the spine an opportunity to approach the apertures and, indeed, to push them away from the center of the catheter (362).
  • the distal-most section (366) is to allow the catheter (362) to align with the nerve roots and prevent the catheter (362) from encircling a nerve root. Again, the catheter, when properly deployed, will have formed a small central area or central volume free of nerve roots and into which the apertures are directed.
  • Fig. 9B shows a top view of the Figure 9A catheter (362).
  • the view shows an open volume (368) within the catheter (362) turns.
  • the shape of the catheter (362) may be wound tighter so that the corkscrew is very "tight."
  • the push to the outside of the catheter (368) is lessened for, e.g., young spines and for smaller cavities.
  • Figure 10A shows a catheter (372) having a design similar to that in Fig. 9A but in which the corkscrew portion is only in the distal section, much like a "pigtail.” This form is often easier to insert through a Touhy needle because of the fewer number of turns. Again, the corkscrew may be wound quite tightly and the apertures are preferably within the inside of the turns of the corkscrew section.
  • Fig. 10B shows a top view of the Figure 10A catheter (372).
  • the shaping of the catheters found in Figures 9 A, 9B, 10 A, and 10B may be produced by heat-shaping during production of the devices either by heating the formed device or by pre-shaping the anti-kinking members discussed above.
  • Figure 11 shows a typical kit having a catheter (382) made using the invention, a Touhy needle (383), an obdurator (384), and a guidewire (385).
  • the obdurator (384) is a simple solid needle having a distal end cut at an angle approximating that of the distal end of the Touhy needle.
  • the obdurator (384) is fit into the Touhy needle (383) upon rotation forms a circular opening in the affected area.
  • Touhy needle (383) is properly situated in the subarachnoid space, the obdurator (384) is removed.
  • the catheter (382) is then placed in the lumen of the Touhy needle (383).
  • Catheter (382) includes apertures (386) and a variety of typical markers (387, 388, and 389).
  • Marker (387) is a double marker which indicates to the user that the distal end of the catheter (382) is at the distal end of the Touhy needle (383).
  • Double marker (388) is a distance marker at, e.g., one inch.
  • Markers (389) are also distance markers depicting, e.g., one-quarter inch.
  • the catheter (420) of the present invention is shown in conjunction with guidewire (410) and Touhy needle (430).
  • the catheter is typically inserted into the subarachnoid space via a Touhy needle such as needle (430) shown in Figure 12D.
  • the catheter typically turns to enter the subarachnoid space along the spinal column axis so that its direction of motion is towards the patient's head.
  • three features may be used. The first is the curved guidewire (410) as shown in Figure 12B.
  • the second is a self-forming distal end on catheter (420).
  • the third is Touhy needle (430) having an asymmetrically curved distal end (440).
  • guidewire (410) having a generally nonlinear proximal end (412) or, as shown in Figure 12 A, a "J" or semicircular-shaped distal end (414) is inserted into the lumen of catheter (420) through its proximal end ( Figure 12C).
  • the distal portion of catheter (420) is flexible enough so that the elongate tubular member making up the catheter takes on an approximation of the shape of the guidewire (410) as shown in Figure 12C.
  • the angle created by this shape can vary, and is preferably between about 35° and 150° so to best facilitate entry into the subarachnoid space.
  • the catheter (420) may have a straight configuration, yet it is flexible and unrestrained.
  • the unrestrained elongate tubular member making up the catheter can be self-forming into a form having an elbow.
  • Such an elbow is depicted in Figures 9A and 10A discussed above.
  • the elbow facilitates catheter placement in the direction of the length of the subarachnoid space when the catheter is oriented properly in the subarachnoid space and the shaped guidewire has been withdrawn from the catheter lumen. It is preferred, but not necessary, that the elbow be proximal to at least one of the apertures herein described so that drainage can be facilitated by allowing fluid to flow into the catheter lumen in a direction other than that of fluid flowing into other apertures.
  • the angle formed between the portions of the tubular member of the catheter distal and proximal to the elbow when deployed can be generally between 60° and 120°.
  • the guidewire-catheter combination is inserted through the Touhy needle into the lumbar region of the spinal column.
  • the elongate tubular member of catheter (420) is flexible enough and sized so that it can pass through a 10 to 18 gauge and preferably a 12 to 15 gauge Touhy needle.
  • the guidewire (410) is proximally withdrawn from catheter (420) and the lumbar drainage procedure can begin.
  • FIG. 13 depicts one possible system for use with the catheter of the present invention.
  • This figure depicts a CSF perfusion-drainage system deployed in a human cerebrospinal system.
  • Inflow catheter (560) is inserted into the brain ventricle (500) so that it accesses the CSF pathway system of the human body.
  • This system allows CSF, or in the case of the perfusion-drainage system of Figure 13, OFNE, to pass through the various regions of the CSF pathway.
  • a lumbar drainage catheter (570) of the present invention is shown in Figure 13 deployed in the subarachnoid space (530) between L4 (reference numeral (540)) and L5
  • the woven cage (624) is a variation of the children's toy ("Chinese Finger Puzzle"). To release the cage (624), a lanyard 9626) is provided.
  • the woven cage assembly (624) is held on the surface of the body by a base (628) fixedly attached to the woven cage (624).
  • the base (628) may include suture openings (630) allowing the woven cage assembly (624) to be affixed to the body by sutures (632) through the skin (631). Pulling on the catheter (622) should not allow movement of the catheter relative to the body.
  • Figure 14B shows the cinching of the lanyard (626) against the lanyard holder (633) to collapse the loosen the woven cage (624) and allow the catheter (622) to move relative to the skin (631).

Abstract

L'invention concerne un ensemble cathéter conçu pour accéder au système de circulation du fluide céphalorachidien et pour drainer un fluide de celui-ci. Le cathéter polymère à paroi mince présente une zone distale molle et souple permettant de réduire au minimum le traumatisme provoqué dans les tissus, et d'accéder de manière coudée à l'espace sous-arachnoïdien de la voie du fluide céphalorachidien au moyen d'un fil-guide facultatif. Une zone proximale plus rigide, pouvant contenir éventuellement une tresse tissée ou un enroulement de renfort, permet d'assurer que le cathéter ne se tortille ou ne se comprime pas à l'utilisation dans les membranes dures situées autour de la colonne vertébrale. Un ou plusieurs orifices situés dans la paroi de cathéter, servant à drainer le fluide de manière proximale par la lumière centrale du cathéter, assure(nt) le transport du fluide à travers le cathéter à des débits et des pressions thérapeutiques. Un bouchon polymère mou, qui peut être placé à l'extrémité distale de l'ensemble cathéter, garantit un traumatisme minimal des tissus lors de la pénétration. Tout le cathéter peut être revêtu à l'aide d'un revêtement hydrophile pour faciliter les déplacements à travers une aiguille facultative du type Touhy et les tissus, et peut être opaque aux rayonnements pour conférer une plus grande visibilité en fluoroscopie.
PCT/US2000/040736 1999-08-24 2000-08-24 Catheter de drainage lombaire WO2001013984A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
KR1020027002380A KR20020026598A (ko) 1999-08-24 2000-08-24 요추 배액 카테테르
MXPA02001866A MXPA02001866A (es) 1999-08-24 2000-08-24 Cateter de drenaje lumbar.
JP2001518116A JP2003507140A (ja) 1999-08-24 2000-08-24 腰椎ドレナージカテーテル
AU80340/00A AU8034000A (en) 1999-08-24 2000-08-24 Lumbar drainage catheter
EP00971044A EP1207931A2 (fr) 1999-08-24 2000-08-24 Catheter de drainage lombaire
CA002382871A CA2382871A1 (fr) 1999-08-24 2000-08-24 Catheter de drainage lombaire

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38213699A 1999-08-24 1999-08-24
US09/382,136 1999-08-24

Publications (3)

Publication Number Publication Date
WO2001013984A2 true WO2001013984A2 (fr) 2001-03-01
WO2001013984A3 WO2001013984A3 (fr) 2001-08-23
WO2001013984A9 WO2001013984A9 (fr) 2001-10-04

Family

ID=23507664

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/040736 WO2001013984A2 (fr) 1999-08-24 2000-08-24 Catheter de drainage lombaire

Country Status (8)

Country Link
EP (1) EP1207931A2 (fr)
JP (1) JP2003507140A (fr)
KR (1) KR20020026598A (fr)
CN (1) CN1370086A (fr)
AU (1) AU8034000A (fr)
CA (1) CA2382871A1 (fr)
MX (1) MXPA02001866A (fr)
WO (1) WO2001013984A2 (fr)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20113545U1 (de) * 2001-08-16 2001-12-20 Rehau Ag & Co Katheter
US20070270767A1 (en) * 2006-05-17 2007-11-22 Xuan Khieu Catheter with aspiration passageway
WO2008024596A2 (fr) * 2006-08-24 2008-02-28 Boston Scientific Limited Appareil médical allongé et méthode pour l'enduire
WO2008070769A1 (fr) * 2006-12-06 2008-06-12 Medtronic, Inc. Cathéter intrathécal
WO2010128249A1 (fr) 2009-05-06 2010-11-11 A.L.N. Kit d'extraction pour filtre pour veine cave
EP2316518A1 (fr) * 2009-10-29 2011-05-04 Asahi Intecc Co., Ltd. Tuyau médical et cathéter l'utilisant
EP2641528A1 (fr) * 2012-03-22 2013-09-25 DePuy Synthes Products LLC Cathéter de gestion de fluide et procédés d'utilisation de celui-ci
WO2015028817A1 (fr) * 2013-08-30 2015-03-05 Braidlock Limited Dispositif de fixation d'une ligne médicale ou chirurgicale
WO2015077750A1 (fr) * 2013-11-25 2015-05-28 Avent, Inc. Système de cathéter
EP2881135A1 (fr) * 2008-10-28 2015-06-10 Braidlock Limited Appareil de sécurisation d'une ligne
WO2019084435A1 (fr) * 2017-10-27 2019-05-02 Boston Scientific Scimed, Inc. Cathéter de drainage tressé
WO2019070392A3 (fr) * 2017-10-08 2019-05-16 Sheibley Medical LLC Cathéter de drainage avec ballonnet
US10493249B2 (en) 2014-04-18 2019-12-03 Anuncia, Inc. System and methods for shunting fluid
US10639461B2 (en) 2013-01-22 2020-05-05 Anuncia, Inc. Systems and methods for shunting fluid
US10792480B2 (en) 2016-10-13 2020-10-06 Anuncia, Inc. Shunt flushers and related methods
RU206348U1 (ru) * 2021-06-28 2021-09-07 Акционерное общество "Научно-производственное предприятие "Полет" Трубка дренажная медицинская

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803150B2 (en) 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US7462175B2 (en) 2004-04-21 2008-12-09 Acclarent, Inc. Devices, systems and methods for treating disorders of the ear, nose and throat
US9089258B2 (en) 2004-04-21 2015-07-28 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US8764729B2 (en) 2004-04-21 2014-07-01 Acclarent, Inc. Frontal sinus spacer
US8702626B1 (en) 2004-04-21 2014-04-22 Acclarent, Inc. Guidewires for performing image guided procedures
US7654997B2 (en) 2004-04-21 2010-02-02 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
US9351750B2 (en) 2004-04-21 2016-05-31 Acclarent, Inc. Devices and methods for treating maxillary sinus disease
US9554691B2 (en) 2004-04-21 2017-01-31 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US20060063973A1 (en) 2004-04-21 2006-03-23 Acclarent, Inc. Methods and apparatus for treating disorders of the ear, nose and throat
US8894614B2 (en) 2004-04-21 2014-11-25 Acclarent, Inc. Devices, systems and methods useable for treating frontal sinusitis
US7419497B2 (en) 2004-04-21 2008-09-02 Acclarent, Inc. Methods for treating ethmoid disease
US20190314620A1 (en) 2004-04-21 2019-10-17 Acclarent, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US10188413B1 (en) 2004-04-21 2019-01-29 Acclarent, Inc. Deflectable guide catheters and related methods
US20070167682A1 (en) 2004-04-21 2007-07-19 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US20070208252A1 (en) 2004-04-21 2007-09-06 Acclarent, Inc. Systems and methods for performing image guided procedures within the ear, nose, throat and paranasal sinuses
US8932276B1 (en) 2004-04-21 2015-01-13 Acclarent, Inc. Shapeable guide catheters and related methods
US9101384B2 (en) 2004-04-21 2015-08-11 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat
US7559925B2 (en) 2006-09-15 2009-07-14 Acclarent Inc. Methods and devices for facilitating visualization in a surgical environment
US9399121B2 (en) 2004-04-21 2016-07-26 Acclarent, Inc. Systems and methods for transnasal dilation of passageways in the ear, nose or throat
US8747389B2 (en) 2004-04-21 2014-06-10 Acclarent, Inc. Systems for treating disorders of the ear, nose and throat
US8951225B2 (en) 2005-06-10 2015-02-10 Acclarent, Inc. Catheters with non-removable guide members useable for treatment of sinusitis
US9820688B2 (en) 2006-09-15 2017-11-21 Acclarent, Inc. Sinus illumination lightwire device
CA2676853C (fr) 2007-02-09 2015-09-29 Steven J. Ferry Systeme pour l'acheminement intraluminal dans le systeme vasculaire vivant
WO2008124787A2 (fr) 2007-04-09 2008-10-16 Acclarent, Inc. Système d'ethmoïdotomie et dispositifs espaceurs implantables capables de délivrer une substance thérapeutique pour le traitement de la sinusite paranasale
US8485199B2 (en) 2007-05-08 2013-07-16 Acclarent, Inc. Methods and devices for protecting nasal turbinate during surgery
CN102112040B (zh) 2008-07-30 2015-04-01 阿克拉伦特公司 鼻旁孔口探示器器件和方法
CN102159276B (zh) 2008-09-18 2014-01-15 阿克拉伦特公司 用于治疗耳鼻喉科疾病的方法和设备
CA2745192C (fr) * 2008-12-31 2017-04-11 Kci Licensing, Inc. Manchons, collecteurs, systemes et procedes d'application d'une pression reduite a un site de tissu sous-cutane
JP2011004977A (ja) * 2009-06-25 2011-01-13 Olympus Corp カテーテル
US9155492B2 (en) 2010-09-24 2015-10-13 Acclarent, Inc. Sinus illumination lightwire device
US20120101511A1 (en) * 2010-10-21 2012-04-26 Myungji You Medical Apparatus for Dissociation of Epidural Adhesion and Diminution of Stenosis of Intervertebral Foramen
JP2012196498A (ja) * 2012-06-14 2012-10-18 Asahi Intecc Co Ltd 医療用チューブ
TWI515025B (zh) * 2012-07-18 2016-01-01 吳麗秋 鼻通道沖洗導管裝置
CN104274868B (zh) * 2013-07-11 2017-06-13 宁波市海曙思力德贸易有限公司 一种引流套件
CN104667409B (zh) * 2015-01-29 2017-11-10 浙江大学 抗挤压引流管及其制造方法
JP6579508B2 (ja) * 2015-02-20 2019-09-25 国立大学法人金沢大学 吸引チューブ
WO2016139590A1 (fr) 2015-03-02 2016-09-09 Accurate Medical Therapeutics Ltd. Particules d'embolisation destinées à l'occlusion d'un vaisseau sanguin
KR102446959B1 (ko) * 2016-05-04 2022-09-23 애커러트 메디컬 테라퓨틱스 엘티디. 슬릿형 패턴을 갖는 색전술 마이크로 카테터 헤드
EP3484567B1 (fr) * 2016-07-13 2020-09-23 Boston Scientific Scimed Inc. Cathéter de perfusion à capacités de haute pression
US11439798B2 (en) 2017-04-24 2022-09-13 Longeviti Neuro Solutions Llc Cerebral spinal fluid shunt plug
US11045632B2 (en) 2017-04-24 2021-06-29 Longeviti Neuro Solutions Llc Cerebral spinal fluid shunt plug
WO2019018802A1 (fr) * 2017-07-21 2019-01-24 Medallion Therapeutics, Inc. Cathéters comprenant des marqueurs radio-opaques et leurs procédés de fabrication
EP3703583A4 (fr) 2017-11-02 2020-12-30 Accurate Medical Therapeutics Ltd. Cathéter d'embolisation avec filtre intégré
CN113181444B (zh) * 2021-05-06 2022-11-15 苏州宇博医疗科技有限公司 防损伤定向引导硬膜下引流方法
KR102606977B1 (ko) * 2021-06-10 2023-11-29 인제대학교 산학협력단 뇌척수액 검사를 위한 카테터 유닛

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3174851A (en) 1961-12-01 1965-03-23 William J Buehler Nickel-base alloys
US3351463A (en) 1965-08-20 1967-11-07 Alexander G Rozner High strength nickel-base alloys
US4378797A (en) 1980-04-14 1983-04-05 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4393863A (en) 1980-04-14 1983-07-19 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4840617A (en) 1980-04-14 1989-06-20 Thomas Jefferson University Cerebral and lumbar perfusion catheterization apparatus for use in treating hypoxic/ischemic neurologic tissue
US4981691A (en) 1980-04-14 1991-01-01 Thomas Jefferson University Oxygenated fluorocarbon nutrient solution
US5531715A (en) 1993-05-12 1996-07-02 Target Therapeutics, Inc. Lubricious catheters
US5538512A (en) 1993-02-25 1996-07-23 Zenzon; Wendy J. Lubricious flow directed catheter

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4385635A (en) * 1980-04-25 1983-05-31 Ruiz Oscar F Angiographic catheter with soft tip end
US4391276A (en) * 1980-12-16 1983-07-05 Harrison Lazarus Peritoneal catheter
US4694838A (en) * 1984-01-30 1987-09-22 Mallinckrodt, Inc. Loop coronary catheter
US5271735A (en) * 1985-10-15 1993-12-21 Albert R. Greenfeld Exterior antimigration refinements for self-cleaning indwelling therapeutic articles
DE69432359T2 (de) * 1993-11-12 2003-12-24 Micro Interventional Systems P Katheter mit kleinem durchmesser und hohem drehmoment
EP0732954B1 (fr) * 1993-12-10 1998-08-19 Schneider (Usa) Inc. Catheter de guidage
US5702372A (en) * 1995-02-08 1997-12-30 Medtronic, Inc. Lined infusion catheter
WO1998035717A1 (fr) * 1996-02-14 1998-08-20 Brown Joe E Element enroule et procede d'administration intravasculaire pour agents diagnostiques et therapeutiques
GB9717821D0 (en) * 1997-08-21 1997-10-29 Spinoza Marc H Fasteners

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3174851A (en) 1961-12-01 1965-03-23 William J Buehler Nickel-base alloys
US3351463A (en) 1965-08-20 1967-11-07 Alexander G Rozner High strength nickel-base alloys
US4378797A (en) 1980-04-14 1983-04-05 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4393863A (en) 1980-04-14 1983-07-19 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4840617A (en) 1980-04-14 1989-06-20 Thomas Jefferson University Cerebral and lumbar perfusion catheterization apparatus for use in treating hypoxic/ischemic neurologic tissue
US4981691A (en) 1980-04-14 1991-01-01 Thomas Jefferson University Oxygenated fluorocarbon nutrient solution
US5538512A (en) 1993-02-25 1996-07-23 Zenzon; Wendy J. Lubricious flow directed catheter
US5531715A (en) 1993-05-12 1996-07-02 Target Therapeutics, Inc. Lubricious catheters

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20113545U1 (de) * 2001-08-16 2001-12-20 Rehau Ag & Co Katheter
US20070270767A1 (en) * 2006-05-17 2007-11-22 Xuan Khieu Catheter with aspiration passageway
US8480636B2 (en) 2006-05-17 2013-07-09 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter with aspiration passageway
US7833564B2 (en) 2006-08-24 2010-11-16 Boston Scientific Scimed, Inc. Elongate medical device and method of coating the same
WO2008024596A2 (fr) * 2006-08-24 2008-02-28 Boston Scientific Limited Appareil médical allongé et méthode pour l'enduire
WO2008024596A3 (fr) * 2006-08-24 2008-10-09 Boston Scient Ltd Appareil médical allongé et méthode pour l'enduire
WO2008070769A1 (fr) * 2006-12-06 2008-06-12 Medtronic, Inc. Cathéter intrathécal
US9072871B2 (en) 2008-10-28 2015-07-07 Braidlock Limited Methods and apparatus for securing a line
EP2349437B1 (fr) * 2008-10-28 2018-08-22 Braidlock Limited Procédés et appareils de fixation d'un conduit
US10632288B2 (en) 2008-10-28 2020-04-28 Braidlock Limited Methods and apparatus for securing a line
US10561824B2 (en) 2008-10-28 2020-02-18 Braidlock Limited Methods and apparatus for securing a line
EP2954922A1 (fr) * 2008-10-28 2015-12-16 Braidlock Limited Procédé et appareil de sécurisation d'une ligne
EP2881135A1 (fr) * 2008-10-28 2015-06-10 Braidlock Limited Appareil de sécurisation d'une ligne
WO2010128249A1 (fr) 2009-05-06 2010-11-11 A.L.N. Kit d'extraction pour filtre pour veine cave
FR2945206A1 (fr) * 2009-05-06 2010-11-12 Aln Kit d'extraction pour filtre pour veine cave
US9381077B2 (en) 2009-05-06 2016-07-05 A.L.N. Extraction kit for a filter for the vena cava
EP2316518A1 (fr) * 2009-10-29 2011-05-04 Asahi Intecc Co., Ltd. Tuyau médical et cathéter l'utilisant
AU2017248500B2 (en) * 2012-03-22 2019-05-09 Integra LifeSciences Switzerland Sarl Fluid management catheter and methods of using same
US9848764B2 (en) 2012-03-22 2017-12-26 Integra Lifesciences Switzerland Sàrl Fluid management catheter and methods of using same
EP2641528A1 (fr) * 2012-03-22 2013-09-25 DePuy Synthes Products LLC Cathéter de gestion de fluide et procédés d'utilisation de celui-ci
US10639461B2 (en) 2013-01-22 2020-05-05 Anuncia, Inc. Systems and methods for shunting fluid
WO2015028817A1 (fr) * 2013-08-30 2015-03-05 Braidlock Limited Dispositif de fixation d'une ligne médicale ou chirurgicale
WO2015077750A1 (fr) * 2013-11-25 2015-05-28 Avent, Inc. Système de cathéter
US10493249B2 (en) 2014-04-18 2019-12-03 Anuncia, Inc. System and methods for shunting fluid
US10792480B2 (en) 2016-10-13 2020-10-06 Anuncia, Inc. Shunt flushers and related methods
WO2019070392A3 (fr) * 2017-10-08 2019-05-16 Sheibley Medical LLC Cathéter de drainage avec ballonnet
WO2019084435A1 (fr) * 2017-10-27 2019-05-02 Boston Scientific Scimed, Inc. Cathéter de drainage tressé
US11202893B2 (en) 2017-10-27 2021-12-21 Boston Scientific Scimed, Inc. Braided drainage catheter
RU206348U1 (ru) * 2021-06-28 2021-09-07 Акционерное общество "Научно-производственное предприятие "Полет" Трубка дренажная медицинская

Also Published As

Publication number Publication date
WO2001013984A3 (fr) 2001-08-23
AU8034000A (en) 2001-03-19
JP2003507140A (ja) 2003-02-25
KR20020026598A (ko) 2002-04-10
MXPA02001866A (es) 2003-09-25
CA2382871A1 (fr) 2001-03-01
CN1370086A (zh) 2002-09-18
EP1207931A2 (fr) 2002-05-29
WO2001013984A9 (fr) 2001-10-04

Similar Documents

Publication Publication Date Title
EP1207931A2 (fr) Catheter de drainage lombaire
US5782811A (en) Kink-resistant braided catheter with distal side holes
EP1804882B1 (fr) Catheter a extremite distale preformee
DE60123970T2 (de) Betätigbarer abgabekatheter für okklusionsanordnung
DE69734602T2 (de) Verstärkter katheter mit einer formbaren distalen spitze
DE60106260T2 (de) Medizinische vorrichtung mit geflecht und spule
CA2182526C (fr) Catheter tresse performant
DE69921477T2 (de) Katheter mit einer versteifung aus verbundmaterial
US6306124B1 (en) Microcatheter
EP0930910B1 (fr) Catheter-guide a poursuite amelioree par fil directeur
WO1998044979A1 (fr) Catheter a trois regions de flexibilites differentes et son procede de production
EP0984806A1 (fr) Catheter flottant muni de multiple raccords progressifs et de marqueurs radio-opaques
KR19990067352A (ko) 소형 방광 꼬리부를 갖는 요관 스텐트
US20090192494A1 (en) Catheter for Blood Removal
US20220008187A1 (en) Ureteral stent for placement in a kidney and bladder
JPH10290841A (ja) マイクロカテーテル
CN117379222A (zh) 专门设计用于弯曲血管尤其是脑血管的栓塞保护装置
WO2017193120A1 (fr) Endoprothèse urétérale

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/9-9/9, DRAWINGS, REPLACED BY NEW PAGES 1/11-11/11; DUE TO LATE TRANSMITTAL BY THE RECEIVINGOFFICE

WWE Wipo information: entry into national phase

Ref document number: 2000971044

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 008118868

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 1020027002380

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2382871

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 1020027002380

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2000971044

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000971044

Country of ref document: EP